JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 176 filers reported holding JUNO THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.85 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,061,000 | +314.5% | 23,649 | +175.7% | 0.10% | +300.0% |
| Q2 2017 | $256,000 | +9.9% | 8,578 | -18.3% | 0.02% | +9.1% |
| Q1 2017 | $233,000 | +145.3% | 10,500 | +108.2% | 0.02% | +100.0% |
| Q4 2016 | $95,000 | +9400.0% | 5,044 | +25120.0% | 0.01% | – |
| Q3 2016 | $1,000 | -94.7% | 20 | -96.0% | 0.00% | -100.0% |
| Q2 2016 | $19,000 | +72.7% | 500 | +66.7% | 0.00% | +50.0% |
| Q1 2016 | $11,000 | -59.3% | 300 | -40.0% | 0.00% | -50.0% |
| Q2 2015 | $27,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|